Gregoire Bernard Morand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gregoire Bernard Morand has a total of 469 co-authors. Here are the top co-authors by number of shared publications:
Gerhard F. Huber
Department of Otorhinolaryngology – Head and Neck Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland
11 shared publicationsNiels J. Rupp
University of Zurich Zurich Switzerland
11 shared publicationsMartina A. Broglie
Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland
10 shared publications- Niels Jan Rupp
Department of Pathology and Molecular Pathology University Hospital Zurich Zurich Switzerland
10 shared publications - Martin W. Huellner
Department of Nuclear Medicine, University Hospital Zurich , 8091 Zurich
9 shared publications - Martina A. Broglie
Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland
9 shared publications
Latest Publications
- Open Access
- 12 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 966
Data-driven biopsychosocial profiles to inform early psycho-oncology triage in head and neck cancer
Purpose: Rapid head and neck cancer (HNC) diagnostic pathways compress assessment and treatment planning into a few days. However, patients differ substantially in their psychological, physical, functional, interpersonal, and medical needs. Single-score distress screening may not capture this heterogeneity. Methods: We analyzed cross-sectional baseline data from 96 adults assessed within an interdisciplinary 72-h fast-track diagnostic program for suspected or newly diagnosed HNC. Five theory-driven, z-standardized domains (psychological distress, physical burden, functional impairment, interpersonal vulnerability, medical complexity) were derived and clustered with k-means. Psychosocial care contacts within 14 days served as an exploratory external criterion and were not used as clustering inputs. Results: A three-cluster solution yielded (i) low burden ( n = 58, 60.4%), (ii) psychologically distressed ( n = 24, 25.0%) with elevated distress and comparatively low medical complexity, and (iii) somatic/functional high burden ( n = 14, 14.6%) characterized by prominent physical and functional burden. Psychosocial care utilization differed only modestly across clusters. Conclusions: Multidimensional profiling in this 72-h HNC pathway yielded clinically interpretable subgroups that may inform needs-based supportive and psychosocial care allocation. Because observed utilization did not map strongly onto profiles, prospective validation is required before clinical implementation .
- 12 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 966
Open AccessData-driven biopsychosocial profiles to inform early psycho-oncology triage in head and neck cancer
Purpose: Rapid head and neck cancer (HNC) diagnostic pathways compress assessment and treatment planning into a few days. However, patients differ substantially in their psychological, physical, functional, interpersonal, and medical needs. Single-score distress screening may not capture this heterogeneity. Methods: We analyzed cross-sectional baseline data from 96 adults assessed within an interdisciplinary 72-h fast-track diagnostic program for suspected or newly diagnosed HNC. Five theory-driven, z-standardized domains (psychological distress, physical burden, functional impairment, interpersonal vulnerability, medical complexity) were derived and clustered with k-means. Psychosocial care contacts within 14 days served as an exploratory external criterion and were not used as clustering inputs. Results: A three-cluster solution yielded (i) low burden ( n = 58, 60.4%), (ii) psychologically distressed ( n = 24, 25.0%) with elevated distress and comparatively low medical complexity, and (iii) somatic/functional high burden ( n = 14, 14.6%) characterized by prominent physical and functional burden. Psychosocial care utilization differed only modestly across clusters. Conclusions: Multidimensional profiling in this 72-h HNC pathway yielded clinically interpretable subgroups that may inform needs-based supportive and psychosocial care allocation. Because observed utilization did not map strongly onto profiles, prospective validation is required before clinical implementation .
- Open Access
- 2 September 2026
- Published by Wiley in Head & Neck
Characterization of Perineural Invasion Parameters for Risk Stratification in Oral Squamous Cell Carcinoma
Background: Perineural invasion (PNI) is an established adverse prognostic factor in oral squamous cell carcinoma (OSCC), but the implications of its extent as well as its relationship with surgical margin status and the extent of microscopic tumor spread remain unclear. Methods: We retrospectively analyzed 165 patients with OSCC treated surgically with curative intent between 2010 and 2019. PNI was assessed for presence, subtype, number of foci, location, and diameter of the largest involved nerve. Associations with margin status and survival outcomes were evaluated using univariate and multivariate analyses. Results: PNI was present in 29 patients (17.6%) and was associated with advanced tumor stage, nodal metastasis, positive surgical margins (HR 3.4, 95% CI 1.1–10.2), and increased use of adjuvant radiotherapy. While PNI presence predicted poorer survival, the diameter of the largest invaded nerve provided superior prognostic discrimination. A cutoff of 200 μm independently predicted disease‐specific survival (HR 5.7, 95% CI 1.7–19.0) and significantly improved multivariable model performance. Conclusions: PNI correlates with positive surgical margins. Quantifying PNI, particularly nerve diameter, enhances prognostic stratification and may inform individualized surgical margin planning in OSCC.
- 2 September 2026
- Published by Wiley in Head & Neck
Open AccessCharacterization of Perineural Invasion Parameters for Risk Stratification in Oral Squamous Cell Carcinoma
Background: Perineural invasion (PNI) is an established adverse prognostic factor in oral squamous cell carcinoma (OSCC), but the implications of its extent as well as its relationship with surgical margin status and the extent of microscopic tumor spread remain unclear. Methods: We retrospectively analyzed 165 patients with OSCC treated surgically with curative intent between 2010 and 2019. PNI was assessed for presence, subtype, number of foci, location, and diameter of the largest involved nerve. Associations with margin status and survival outcomes were evaluated using univariate and multivariate analyses. Results: PNI was present in 29 patients (17.6%) and was associated with advanced tumor stage, nodal metastasis, positive surgical margins (HR 3.4, 95% CI 1.1–10.2), and increased use of adjuvant radiotherapy. While PNI presence predicted poorer survival, the diameter of the largest invaded nerve provided superior prognostic discrimination. A cutoff of 200 μm independently predicted disease‐specific survival (HR 5.7, 95% CI 1.7–19.0) and significantly improved multivariable model performance. Conclusions: PNI correlates with positive surgical margins. Quantifying PNI, particularly nerve diameter, enhances prognostic stratification and may inform individualized surgical margin planning in OSCC.
- Open Access
- 14 May 2026
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 59
Personalized volume de-escalated elective nodal irradiation in oropharyngeal squamous cell carcinoma (DeEscO): a study protocol
- 14 May 2026
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 59
Open AccessPersonalized volume de-escalated elective nodal irradiation in oropharyngeal squamous cell carcinoma (DeEscO): a study protocol
- Open Access
- 8 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 43365
Diagnostic value, sensitivity and specificity of CT, MRI, and PET in evaluation of cartilage invasion in laryngeal and hypopharyngeal cancer
In advanced laryngeal (LSCC) and hypopharyngeal squamous cell carcinoma (HPSCC), concurrent chemoradiation is the standard approach for organ preservation. However, in T4a disease, upfront surgery followed by adjuvant radio(chemo)therapy is recommended due to suboptimal outcomes with non-surgical treatment. Since cartilage invasion is the principal determinant of T4 staging, its accurate detection is essential for optimal treatment selection. The comparative diagnostic performance of CT, MRI, and FDG-PET in this setting remains uncertain. This retrospective study included 204 patients with LSCC or HPSCC treated between 2010 and 2019 at a tertiary cancer center. All patients underwent pre-therapeutic hybrid FDG-PET combined with CT and/or MRI. Demographic, clinical, and imaging data were collected. Diagnostic accuracy for cartilage invasion was assessed against histopathological findings, and the prevalence of imaging artifacts was analyzed. The study included 204 patients. CT demonstrated higher specificity than MRI for detecting cartilage invasion (86.7% vs. 70.0%), whereas MRI showed greater sensitivity than CT (80.0% vs. 77.1%) but was limited by motion artifacts in 20% of cases. FDG-PET-based metabolic assessment revealed that elevated tumoral SUVmax correlated with cartilage invasion in upfront surgery cases (p = 0.043) but not in salvage surgery cases (p = 0.90). CT is more reliable than MRI for detecting cartilage invasion in LSCC and HPSCC, particularly in patients prone to motion artifacts. FDG-PET adds diagnostic value in upfront surgery candidates, supporting the combined use of CT and PET as the preferred preoperative imaging strategy.
- 8 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 43365
Open AccessDiagnostic value, sensitivity and specificity of CT, MRI, and PET in evaluation of cartilage invasion in laryngeal and hypopharyngeal cancer
In advanced laryngeal (LSCC) and hypopharyngeal squamous cell carcinoma (HPSCC), concurrent chemoradiation is the standard approach for organ preservation. However, in T4a disease, upfront surgery followed by adjuvant radio(chemo)therapy is recommended due to suboptimal outcomes with non-surgical treatment. Since cartilage invasion is the principal determinant of T4 staging, its accurate detection is essential for optimal treatment selection. The comparative diagnostic performance of CT, MRI, and FDG-PET in this setting remains uncertain. This retrospective study included 204 patients with LSCC or HPSCC treated between 2010 and 2019 at a tertiary cancer center. All patients underwent pre-therapeutic hybrid FDG-PET combined with CT and/or MRI. Demographic, clinical, and imaging data were collected. Diagnostic accuracy for cartilage invasion was assessed against histopathological findings, and the prevalence of imaging artifacts was analyzed. The study included 204 patients. CT demonstrated higher specificity than MRI for detecting cartilage invasion (86.7% vs. 70.0%), whereas MRI showed greater sensitivity than CT (80.0% vs. 77.1%) but was limited by motion artifacts in 20% of cases. FDG-PET-based metabolic assessment revealed that elevated tumoral SUVmax correlated with cartilage invasion in upfront surgery cases (p = 0.043) but not in salvage surgery cases (p = 0.90). CT is more reliable than MRI for detecting cartilage invasion in LSCC and HPSCC, particularly in patients prone to motion artifacts. FDG-PET adds diagnostic value in upfront surgery candidates, supporting the combined use of CT and PET as the preferred preoperative imaging strategy.
- Open Access
- 1 December 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (12) , 8218-8220
Sentinel lymph node biopsy in early oral cancer: interpreting high significance in low-event cohorts
Sentinel lymph node biopsy in early oral cancer: interpreting high significance in low-event cohorts
- 1 December 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (12) , 8218-8220
Open AccessSentinel lymph node biopsy in early oral cancer: interpreting high significance in low-event cohorts
Sentinel lymph node biopsy in early oral cancer: interpreting high significance in low-event cohorts
- Open Access
- 23 September 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (5) , e70246
Practice Patterns in Management of Low‐ to Intermediate‐Grade Salivary Gland Carcinoma: A Multi‐Institutional Study
Objectives: To characterize practice patterns and outcomes in the management of low‐ and intermediate‐grade salivary gland carcinoma prior to the existence of treatment guidelines. Methods: Analysis of a registry of patients who underwent parotid and submandibular gland resections for low‐and intermediate‐grade carcinomas between 2010 and 2019. Results: Of all 786 patients included in the study, 726 (92%) had preoperative imaging and 653 (83%) had preoperative biopsy. Of the 729 patients with parotid gland cancer, the majority underwent superficial ( n = 384, 53%) or total ( n = 254, 35%) parotidectomy. In patients with facial nerve preservation, total parotidectomy was associated with a significant increase in transient facial weakness (72/177 (41%) vs. 82/311 (26%), RR 0.65, 95% CI 0.50–0.84, p < 0.05) and permanent facial nerve weakness (23/176 (13%) vs. 16/301 (5%), RR 0.41, 95% CI 0.22–0.75, p < 0.05) compared to superficial parotidectomy. Adjuvant radiation therapy ( RT ) was delivered to 285 (36%) patients. The proportion of patients receiving adjuvant RT declined significantly over the time period from 2015 to 2019 compared to 2010 to 2014 at 162/504 (32%) and 123/282 (44%), respectively ( RR 0.74, 95% CI 0.61–0.89, p < 0.05). When comparing the time periods from 2015 to 2019 and 2010 to 2014, there was no significant difference in local control rates ( RR 0.52, 95% CI 0.26–1.04, p = 0.06) or regional control rates ( RR 0.75, 95% CI 0.26–2.13, p = 0.58). Conclusions: Management of low‐ and intermediate‐grade salivary cancer from 2010 to 2019 was variable, which is expected given the rarity and heterogeneity of the disease and the lack of treatment guidelines prior to 2021. Most patients with parotid malignancies underwent superficial or total parotidectomy. The extent of parotidectomy had an impact on facial nerve function outcomes. Delivery of adjuvant radiation trended down with time. The data presented here will support dissemination of the guidelines and provide data that could inform future trials. Level of Evidence: 2b.
- 23 September 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (5) , e70246
Open AccessPractice Patterns in Management of Low‐ to Intermediate‐Grade Salivary Gland Carcinoma: A Multi‐Institutional Study
Objectives: To characterize practice patterns and outcomes in the management of low‐ and intermediate‐grade salivary gland carcinoma prior to the existence of treatment guidelines. Methods: Analysis of a registry of patients who underwent parotid and submandibular gland resections for low‐and intermediate‐grade carcinomas between 2010 and 2019. Results: Of all 786 patients included in the study, 726 (92%) had preoperative imaging and 653 (83%) had preoperative biopsy. Of the 729 patients with parotid gland cancer, the majority underwent superficial ( n = 384, 53%) or total ( n = 254, 35%) parotidectomy. In patients with facial nerve preservation, total parotidectomy was associated with a significant increase in transient facial weakness (72/177 (41%) vs. 82/311 (26%), RR 0.65, 95% CI 0.50–0.84, p < 0.05) and permanent facial nerve weakness (23/176 (13%) vs. 16/301 (5%), RR 0.41, 95% CI 0.22–0.75, p < 0.05) compared to superficial parotidectomy. Adjuvant radiation therapy ( RT ) was delivered to 285 (36%) patients. The proportion of patients receiving adjuvant RT declined significantly over the time period from 2015 to 2019 compared to 2010 to 2014 at 162/504 (32%) and 123/282 (44%), respectively ( RR 0.74, 95% CI 0.61–0.89, p < 0.05). When comparing the time periods from 2015 to 2019 and 2010 to 2014, there was no significant difference in local control rates ( RR 0.52, 95% CI 0.26–1.04, p = 0.06) or regional control rates ( RR 0.75, 95% CI 0.26–2.13, p = 0.58). Conclusions: Management of low‐ and intermediate‐grade salivary cancer from 2010 to 2019 was variable, which is expected given the rarity and heterogeneity of the disease and the lack of treatment guidelines prior to 2021. Most patients with parotid malignancies underwent superficial or total parotidectomy. The extent of parotidectomy had an impact on facial nerve function outcomes. Delivery of adjuvant radiation trended down with time. The data presented here will support dissemination of the guidelines and provide data that could inform future trials. Level of Evidence: 2b.
- Open Access
- 18 September 2025
- Published by Wiley in Clinical Endocrinology
- Vol. 104 (1) , 67-74
Guiding Management of Bethesda V Thyroid Nodules: The Role of Molecular Testing
Objective: The 2023 Bethesda System update introduced molecular testing as a management option for Bethesda V cytology nodules, aiming to guide surgical decision‐making. This study investigates the correlation between molecular profiling and malignancy aggressiveness. Design: We conducted a retrospective multicenter study involving patients with Bethesda V cytology and confirmed malignant pathology who underwent molecular profiling between 2018 and 2021. Patients: A total of 156 patients with Bethesda V cytology and final malignant histology were included. Measurements: Malignancy aggressiveness was assessed based on histopathological features following 2015 ATA guidelines. Demographic data, pathology results, and genetic variants were analyzed. Molecular profiling results were stratified according to variant risk levels. Results: We identified 161 Bethesda V nodules, of which 153 (95.0%) were malignant on final pathology. Genetic stratification revealed no detected mutations in 39.7% ( n = 56), low‐risk ( n = 49, 31.4%), and intermediate‐risk variants ( n = 45, 28.8%). Only one patient had a high‐risk variant. Patients with intermediate‐risk variants had a sixfold risk of aggressive disease compared to those with low‐risk variants (49% vs. 8.2%, p < 0.001). RAS mutations were the most common among the low‐risk group (68.8%) and BRAF V600E predominated in the intermediate‐risk group (93.3%). Conclusions: Our findings suggest that molecular profiling offers insights into risk stratification for Bethesda V thyroid lesions, demonstrating a very low incidence of aggressive pathology in the low‐risk molecular group.
- 18 September 2025
- Published by Wiley in Clinical Endocrinology
- Vol. 104 (1) , 67-74
Open AccessGuiding Management of Bethesda V Thyroid Nodules: The Role of Molecular Testing
Objective: The 2023 Bethesda System update introduced molecular testing as a management option for Bethesda V cytology nodules, aiming to guide surgical decision‐making. This study investigates the correlation between molecular profiling and malignancy aggressiveness. Design: We conducted a retrospective multicenter study involving patients with Bethesda V cytology and confirmed malignant pathology who underwent molecular profiling between 2018 and 2021. Patients: A total of 156 patients with Bethesda V cytology and final malignant histology were included. Measurements: Malignancy aggressiveness was assessed based on histopathological features following 2015 ATA guidelines. Demographic data, pathology results, and genetic variants were analyzed. Molecular profiling results were stratified according to variant risk levels. Results: We identified 161 Bethesda V nodules, of which 153 (95.0%) were malignant on final pathology. Genetic stratification revealed no detected mutations in 39.7% ( n = 56), low‐risk ( n = 49, 31.4%), and intermediate‐risk variants ( n = 45, 28.8%). Only one patient had a high‐risk variant. Patients with intermediate‐risk variants had a sixfold risk of aggressive disease compared to those with low‐risk variants (49% vs. 8.2%, p < 0.001). RAS mutations were the most common among the low‐risk group (68.8%) and BRAF V600E predominated in the intermediate‐risk group (93.3%). Conclusions: Our findings suggest that molecular profiling offers insights into risk stratification for Bethesda V thyroid lesions, demonstrating a very low incidence of aggressive pathology in the low‐risk molecular group.
- Open Access
- 17 July 2025
- Published by Elsevier in Oral Oncology Reports
- Vol. 15
Supraclavicular flap for pharyngocutanous fistula closure after laryng(pharyng)ectomy in the vessel depleted neck: A case series
- 17 July 2025
- Published by Elsevier in Oral Oncology Reports
- Vol. 15
Open AccessSupraclavicular flap for pharyngocutanous fistula closure after laryng(pharyng)ectomy in the vessel depleted neck: A case series
- Open Access
- 8 April 2025
- Published by Springer Nature in Thyroid Research
- Vol. 18 (1) , 1-8
Molecular alteration patterns predict tumor behavior in papillary thyroid carcinoma independent of tumor size: insights from an international multicenter retrospective study
Molecular testing is a well-established tool that assists in the management of thyroid nodules and allows classification in distinct molecular alteration patterns: BRAF-like, RAS-like and non-BRAF-non-RAS (NBNR). Yet classical TNM classification and ATA guidelines currently rely on tumor size for risk stratification. In this study, we compared tumor behavior according to molecular alteration patterns versus tumor size. Retrospective multicenter multinational study of thyroid nodules that underwent preoperative molecular profiling with ThyGenX/ThyGeNEXT or ThyroSeq V3 between 2015 and 2022. Clinical characteristics, including demographics, cytology results, tumor size, surgical pathology, and molecular alterations, were analyzed. The study included 718 patients who underwent surgery for papillary thyroid cancer, with a majority of 556 (77.4%) being female. The distribution of molecular alteration patterns was as follows: BRAF-like in 227 (31.6%), RAS-like in 171 (23.8%), NBNR in 59 (8.2%), BRAF/RAS overlap 8 (1.1%) and no detectable mutation in 224 (31.2%) cases. The median tumor size was 15 mm (IQR 10–24). Extrathyroidal extension (ETE) was observed in 6.2% of cases with gross ETE and 5.6% with minimal ETE. Notably, nodules with BRAF-like molecular alterations were more likely to exhibit ETE compared to those with RAS-like or NBNR alterations (P < 0.001). There was no significant correlation between ETE and median tumor size (P > 0.05). Molecular testing of thyroid nodules provides a more accurate prediction of tumor behavior compared to tumor size alone. These findings suggest that future staging systems could benefit from incorporating molecular alteration patterns into their algorithms. - Retrospective multinational study on molecular profiling in thyroid cancer. - Vast majority of patients had T1 and T2 tumors (less than 4cm). - Nodules with BRAF-like alterations were more commonly associated with extrathyroideal extension and nodal metastasis. - Tumor size alone was not a predictor of extrathyroideal extension and/or nodal metastasis. - Molecular profiling may be a better predictor of tumor behaviour than tumor size, at least in tumors less than 4cm.
- 8 April 2025
- Published by Springer Nature in Thyroid Research
- Vol. 18 (1) , 1-8
Open AccessMolecular alteration patterns predict tumor behavior in papillary thyroid carcinoma independent of tumor size: insights from an international multicenter retrospective study
Molecular testing is a well-established tool that assists in the management of thyroid nodules and allows classification in distinct molecular alteration patterns: BRAF-like, RAS-like and non-BRAF-non-RAS (NBNR). Yet classical TNM classification and ATA guidelines currently rely on tumor size for risk stratification. In this study, we compared tumor behavior according to molecular alteration patterns versus tumor size. Retrospective multicenter multinational study of thyroid nodules that underwent preoperative molecular profiling with ThyGenX/ThyGeNEXT or ThyroSeq V3 between 2015 and 2022. Clinical characteristics, including demographics, cytology results, tumor size, surgical pathology, and molecular alterations, were analyzed. The study included 718 patients who underwent surgery for papillary thyroid cancer, with a majority of 556 (77.4%) being female. The distribution of molecular alteration patterns was as follows: BRAF-like in 227 (31.6%), RAS-like in 171 (23.8%), NBNR in 59 (8.2%), BRAF/RAS overlap 8 (1.1%) and no detectable mutation in 224 (31.2%) cases. The median tumor size was 15 mm (IQR 10–24). Extrathyroidal extension (ETE) was observed in 6.2% of cases with gross ETE and 5.6% with minimal ETE. Notably, nodules with BRAF-like molecular alterations were more likely to exhibit ETE compared to those with RAS-like or NBNR alterations (P < 0.001). There was no significant correlation between ETE and median tumor size (P > 0.05). Molecular testing of thyroid nodules provides a more accurate prediction of tumor behavior compared to tumor size alone. These findings suggest that future staging systems could benefit from incorporating molecular alteration patterns into their algorithms. - Retrospective multinational study on molecular profiling in thyroid cancer. - Vast majority of patients had T1 and T2 tumors (less than 4cm). - Nodules with BRAF-like alterations were more commonly associated with extrathyroideal extension and nodal metastasis. - Tumor size alone was not a predictor of extrathyroideal extension and/or nodal metastasis. - Molecular profiling may be a better predictor of tumor behaviour than tumor size, at least in tumors less than 4cm.
- Open Access
- 21 January 2025
- Published by Elsevier in Oral Oncology Reports
- Vol. 13
Early-stage oral cavity cancer (T1N0) with lymphatic drainage to the retropharyngeal lymph node: A therapeutic challenge
- 21 January 2025
- Published by Elsevier in Oral Oncology Reports
- Vol. 13
Open AccessEarly-stage oral cavity cancer (T1N0) with lymphatic drainage to the retropharyngeal lymph node: A therapeutic challenge